-
FDA approves Galderma's Mirvaso for redness of rosacea
FORT WORTH, Texas — The Food and Drug Administration has approved a drug made by Galderma Labs for treating a side effect of rosacea in adults, the company said.
Galderma announced the approval of Mirvaso (brimonidine) topical gel in the 0.33% strength for the topical treatment of facial erythema of rosacea. The drug is applied once per day to reduce redness and lasts up to 12 hours. The company expects the drug to become available in pharmacies next month.
-
Pure Encapsulations launches four specialty supplement formulas to support brain function
SUDBURY, Mass. — Pure Encapsulations on Tuesday launched its PureSynapse product line, including SeroPlus, DopaPlus, NeuroPure and Amino Replete, four specialty formulas to support emotional health, memory and behavior that was formulated with James Greenblatt, an author and lecturer who is dedicated to integrative psychiatry.
“As we begin to better understand nutritional deficiencies and toxic environmental chemicals that interfere with brain function, we are better able to provide safe and effective support for mental health,” Greenblatt stated.